To date, only 37 of 194 countries that signed up to implement the WHO Global action plan on dementia have created and funded national dementia plans. Our new campaign aims to galvanise and encourage more governments to develop national dementia plans following their 2017 commitment.
The study by Institute for Health Metrics and Evaluation (IHME) published in The Lancet predicts 153 million people will be living with Alzheimer’s disease by 2050.
The news follows a negative vote trend by the Committee for Medicinal Products for Human Use (CHMP) at their oral explanation meeting.
In this blog, the co-leaders of the Brain Health Diplomacy Working Group from The Global Brain Health Institute (GBHI), write about the necessity for brain health diplomacy in advancing better brain health.
Raymond Xiong writes about his inspiration behind creating and sharing MECA exercises, which incorporate music, gymnastics and cognitive activity, to improve the wellbeing of people living with dementia.
The annual Alzheimer University (AU) assists emerging Alzheimer and dementia associations.
ADI has partnered with ITN Productions Industry to produce the news-style documentary Building on Hope.
World Alzheimers Month 2021 has just ended and marks the most successful awareness raising campaign to date in its decade long history.
Eisai’s lecanemab will represent the second anti-Amyloid Beta therapy to be evaluated by the FDA as a disease modifying treatment for early Alzheimer’s disease.
This is the press release for the World Alzheimer Report 2021 'Journey through the diagnosis of dementia'